Axogen, Inc. — Director's Dealing 2022

Dec 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-12-14

Reporting Person: MARIANI PETER J (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-14	Common Stock	M	19364	$5.04	Acquired	49062	Direct
2022-12-14	Common Stock	F	8930	$10.93	Disposed	40132	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-15	Employee Stock Option (right to purchase)	$5.04	M	19364	Disposed	2023-03-01	Common Stock (19364.0)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 19,364 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 10,434 shares of common stock.